TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/20 16:30 | 8/13/20 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | S | -138 | 2.75 | 0 | -50 | -2 | 2,500 | D | ||||||||||||||
3/27/20 19:15 | 3/26/20 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | S | -175 | 1.75 | 0 | -100 | -4 | 2,550 | D | ||||||||||||||
12/26/17 15:02 | 12/21/17 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | S | -977 | 2.30 | 0 | -425 | -15 | 2,485 | D | ||||||||||||||
10/2/17 12:53 | 9/29/17 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | S | -839 | 2.30 | 0 | -365 | -14 | 2,310 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |